Chile Financial Markets News
Sign up for free!
Get instant access to all of our market news and analysis with our free REST API.
Latest news
Live response for past 24 hours
{
"meta": {
"found": 283,
"returned": 10,
"limit": 10,
"page": 1
},
"data": [
{
"uuid": "85fd80a5-bf1a-4b08-8837-1e95148a9cf7",
"title": "Key Pivot Points for iShares Trust Russell 2000 (IWM) | IWM Stock News",
"description": "The iShares Trust Russell 2000 Index Fund (IWM) has recently highlighted its pivot points, calculated using the DeMark methodology. Currently, the pivot high is",
"keywords": "GuruFocus, Article, News, GuruFocus News, IWM",
"snippet": "The iShares Trust Russell 2000 Index Fund (IWM, Financial) has recently highlighted its pivot points, calculated using the DeMark methodology. Currently, the pi...",
"url": "https://www.gurufocus.com/news/2811534/key-pivot-points-for-ishares-trust-russell-2000-iwm-iwm-stock-news",
"image_url": "https://static.gurufocus.com/images/global_logo_twitter_card.png",
"language": "en",
"published_at": "2025-04-29T13:46:06.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "IBB.SN",
"name": "ISHARES TRUST",
"exchange": null,
"exchange_long": null,
"country": "cl",
"type": "equity",
"industry": "N/A",
"match_score": 94.45382,
"sentiment_score": -0.1366,
"highlights": [
{
"highlight": "The <em>iShares</em> <em>Trust</em> Russ[+280 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "Key Pivot Points for <em>iShares</em> <em>Trust</em> Russell 2000 (IWM) | IWM Stock News",
"sentiment": 0,
"highlighted_in": "title"
}
]
},
{
"symbol": "INDA-CL.SN",
"name": "ISHARES TRUST",
"exchange": null,
"exchange_long": null,
"country": "cl",
"type": "equity",
"industry": "N/A",
"match_score": 94.45382,
"sentiment_score": -0.1366,
"highlights": [
{
"highlight": "The <em>iShares</em> <em>Trust</em> Russ[+280 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "Key Pivot Points for <em>iShares</em> <em>Trust</em> Russell 2000 (IWM) | IWM Stock News",
"sentiment": 0,
"highlighted_in": "title"
}
]
},
{
"symbol": "IBB-CL.SN",
"name": "ISHARES TRUST",
"exchange": null,
"exchange_long": null,
"country": "cl",
"type": "equity",
"industry": "N/A",
"match_score": 94.45382,
"sentiment_score": -0.1366,
"highlights": [
{
"highlight": "The <em>iShares</em> <em>Trust</em> Russ[+280 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "Key Pivot Points for <em>iShares</em> <em>Trust</em> Russell 2000 (IWM) | IWM Stock News",
"sentiment": 0,
"highlighted_in": "title"
}
]
},
{
"symbol": "EMB-CL.SN",
"name": "ISHARES TRUST",
"exchange": null,
"exchange_long": null,
"country": "cl",
"type": "equity",
"industry": "N/A",
"match_score": 94.45382,
"sentiment_score": -0.1366,
"highlights": [
{
"highlight": "The <em>iShares</em> <em>Trust</em> Russ[+280 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "Key Pivot Points for <em>iShares</em> <em>Trust</em> Russell 2000 (IWM) | IWM Stock News",
"sentiment": 0,
"highlighted_in": "title"
}
]
},
{
"symbol": "IYG.SN",
"name": "ISHARES TRUST",
"exchange": null,
"exchange_long": null,
"country": "cl",
"type": "equity",
"industry": "N/A",
"match_score": 94.45362,
"sentiment_score": -0.1366,
"highlights": [
{
"highlight": "The <em>iShares</em> <em>Trust</em> Russ[+280 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "Key Pivot Points for <em>iShares</em> <em>Trust</em> Russell 2000 (IWM) | IWM Stock News",
"sentiment": 0,
"highlighted_in": "title"
}
]
},
{
"symbol": "IYH-CL.SN",
"name": "ISHARES TRUST",
"exchange": null,
"exchange_long": null,
"country": "cl",
"type": "equity",
"industry": "N/A",
"match_score": 94.45362,
"sentiment_score": -0.1366,
"highlights": [
{
"highlight": "The <em>iShares</em> <em>Trust</em> Russ[+280 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "Key Pivot Points for <em>iShares</em> <em>Trust</em> Russell 2000 (IWM) | IWM Stock News",
"sentiment": 0,
"highlighted_in": "title"
}
]
},
{
"symbol": "EUFN.SN",
"name": "ISHARES TRUST",
"exchange": null,
"exchange_long": null,
"country": "cl",
"type": "equity",
"industry": "N/A",
"match_score": 94.45362,
"sentiment_score": -0.1366,
"highlights": [
{
"highlight": "The <em>iShares</em> <em>Trust</em> Russ[+280 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "Key Pivot Points for <em>iShares</em> <em>Trust</em> Russell 2000 (IWM) | IWM Stock News",
"sentiment": 0,
"highlighted_in": "title"
}
]
},
{
"symbol": "IYG-CL.SN",
"name": "ISHARES TRUST",
"exchange": null,
"exchange_long": null,
"country": "cl",
"type": "equity",
"industry": "N/A",
"match_score": 94.45362,
"sentiment_score": -0.1366,
"highlights": [
{
"highlight": "The <em>iShares</em> <em>Trust</em> Russ[+280 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "Key Pivot Points for <em>iShares</em> <em>Trust</em> Russell 2000 (IWM) | IWM Stock News",
"sentiment": 0,
"highlighted_in": "title"
}
]
},
{
"symbol": "ITBCL.SN",
"name": "ISHARES TRUST",
"exchange": null,
"exchange_long": null,
"country": "cl",
"type": "equity",
"industry": "N/A",
"match_score": 94.45362,
"sentiment_score": -0.1366,
"highlights": [
{
"highlight": "The <em>iShares</em> <em>Trust</em> Russ[+280 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "Key Pivot Points for <em>iShares</em> <em>Trust</em> Russell 2000 (IWM) | IWM Stock News",
"sentiment": 0,
"highlighted_in": "title"
}
]
},
{
"symbol": "TLT-CL.SN",
"name": "ISHARES TRUST",
"exchange": null,
"exchange_long": null,
"country": "cl",
"type": "equity",
"industry": "N/A",
"match_score": 94.45362,
"sentiment_score": -0.1366,
"highlights": [
{
"highlight": "The <em>iShares</em> <em>Trust</em> Russ[+280 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "Key Pivot Points for <em>iShares</em> <em>Trust</em> Russell 2000 (IWM) | IWM Stock News",
"sentiment": 0,
"highlighted_in": "title"
}
]
},
{
"symbol": "HDV-CL.SN",
"name": "ISHARES TRUST",
"exchange": null,
"exchange_long": null,
"country": "cl",
"type": "equity",
"industry": "N/A",
"match_score": 94.45362,
"sentiment_score": -0.1366,
"highlights": [
{
"highlight": "The <em>iShares</em> <em>Trust</em> Russ[+280 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "Key Pivot Points for <em>iShares</em> <em>Trust</em> Russell 2000 (IWM) | IWM Stock News",
"sentiment": 0,
"highlighted_in": "title"
}
]
},
{
"symbol": "IYMCL.SN",
"name": "ISHARES TRUST",
"exchange": null,
"exchange_long": null,
"country": "cl",
"type": "equity",
"industry": "N/A",
"match_score": 94.45362,
"sentiment_score": -0.1366,
"highlights": [
{
"highlight": "The <em>iShares</em> <em>Trust</em> Russ[+280 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "Key Pivot Points for <em>iShares</em> <em>Trust</em> Russell 2000 (IWM) | IWM Stock News",
"sentiment": 0,
"highlighted_in": "title"
}
]
},
{
"symbol": "IGE.SN",
"name": "ISHARES TRUST",
"exchange": null,
"exchange_long": null,
"country": "cl",
"type": "equity",
"industry": "N/A",
"match_score": 94.45362,
"sentiment_score": -0.1366,
"highlights": [
{
"highlight": "The <em>iShares</em> <em>Trust</em> Russ[+280 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "Key Pivot Points for <em>iShares</em> <em>Trust</em> Russell 2000 (IWM) | IWM Stock News",
"sentiment": 0,
"highlighted_in": "title"
}
]
},
{
"symbol": "EFACL.SN",
"name": "ISHARES TRUST",
"exchange": null,
"exchange_long": null,
"country": "cl",
"type": "equity",
"industry": "N/A",
"match_score": 94.45362,
"sentiment_score": -0.1366,
"highlights": [
{
"highlight": "The <em>iShares</em> <em>Trust</em> Russ[+280 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "Key Pivot Points for <em>iShares</em> <em>Trust</em> Russell 2000 (IWM) | IWM Stock News",
"sentiment": 0,
"highlighted_in": "title"
}
]
},
{
"symbol": "FLOT.SN",
"name": "ISHARES TRUST",
"exchange": null,
"exchange_long": null,
"country": "cl",
"type": "equity",
"industry": "N/A",
"match_score": 94.45362,
"sentiment_score": -0.1366,
"highlights": [
{
"highlight": "The <em>iShares</em> <em>Trust</em> Russ[+280 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "Key Pivot Points for <em>iShares</em> <em>Trust</em> Russell 2000 (IWM) | IWM Stock News",
"sentiment": 0,
"highlighted_in": "title"
}
]
},
{
"symbol": "IEI.SN",
"name": "ISHARES TRUST",
"exchange": null,
"exchange_long": null,
"country": "cl",
"type": "equity",
"industry": "N/A",
"match_score": 94.45362,
"sentiment_score": -0.1366,
"highlights": [
{
"highlight": "The <em>iShares</em> <em>Trust</em> Russ[+280 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "Key Pivot Points for <em>iShares</em> <em>Trust</em> Russell 2000 (IWM) | IWM Stock News",
"sentiment": 0,
"highlighted_in": "title"
}
]
},
{
"symbol": "IWS.SN",
"name": "ISHARES TRUST",
"exchange": null,
"exchange_long": null,
"country": "cl",
"type": "equity",
"industry": "N/A",
"match_score": 94.45362,
"sentiment_score": -0.1366,
"highlights": [
{
"highlight": "The <em>iShares</em> <em>Trust</em> Russ[+280 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "Key Pivot Points for <em>iShares</em> <em>Trust</em> Russell 2000 (IWM) | IWM Stock News",
"sentiment": 0,
"highlighted_in": "title"
}
]
},
{
"symbol": "FXICL.SN",
"name": "ISHARES TRUST",
"exchange": null,
"exchange_long": null,
"country": "cl",
"type": "equity",
"industry": "N/A",
"match_score": 94.45362,
"sentiment_score": -0.1366,
"highlights": [
{
"highlight": "The <em>iShares</em> <em>Trust</em> Russ[+280 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "Key Pivot Points for <em>iShares</em> <em>Trust</em> Russell 2000 (IWM) | IWM Stock News",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
],
"similar": []
},
{
"uuid": "44c6538a-c8c7-4a6a-b844-d50afac6dfdc",
"title": "Pfizer Inc. Reports Q1 2025 Earnings: EPS of $0.52 Beats Estimates, Revenue at $13.7 Billion Misses Expectations",
"description": "Revenue: $13.7 billion, slightly below the estimated $13.95 billion, reflecting an 8% year-over-year decline.Reported Diluted EPS: $0.52, surpassing the estima",
"keywords": "GuruFocus, Article, News, GuruFocus News, PFE",
"snippet": "On April 29, 2025, Pfizer Inc (PFE, Financial) released its 8-K filing detailing its financial performance for the first quarter of 2025. The pharmaceutical gia...",
"url": "https://www.gurufocus.com/news/2811490/pfizer-inc-reports-q1-2025-earnings-eps-of-052-beats-estimates-revenue-at-137-billion-misses-expectations",
"image_url": "https://static.gurufocus.com/logos/0C00000C7U.png?5",
"language": "en",
"published_at": "2025-04-29T13:31:09.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "PFECL.SN",
"name": "PFIZER INC",
"exchange": null,
"exchange_long": null,
"country": "cl",
"type": "equity",
"industry": "N/A",
"match_score": 57.07483,
"sentiment_score": 0.1531,
"highlights": [
{
"highlight": "On April 29, 2025, <em>Pfizer</em> <em>I[+232 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Pfizer</em> reaffirmed its full-year[+316 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Pfizer</em> operates globally, with [+259 characters]",
"sentiment": 0.4019,
"highlighted_in": "main_text"
},
{
"highlight": "Albert Bourla, Chairman and CEO of <em>P[+186 characters]",
"sentiment": 0.743,
"highlighted_in": "main_text"
},
{
"highlight": "Explore the complete 8-K earnings releas[+63 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Pfizer</em> <em>Inc</em>. Reports Q1 2025 Earnings: EPS of $0.52 Beats Estimates, Revenue at $13.7 Billion Misses Expectations",
"sentiment": -0.2263,
"highlighted_in": "title"
}
]
},
{
"symbol": "PFE.SN",
"name": "Pfizer Inc.",
"exchange": null,
"exchange_long": null,
"country": "cl",
"type": "equity",
"industry": "Healthcare",
"match_score": 57.07483,
"sentiment_score": 0.1531,
"highlights": [
{
"highlight": "On April 29, 2025, <em>Pfizer</em> <em>I[+232 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Pfizer</em> reaffirmed its full-year[+316 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Pfizer</em> operates globally, with [+259 characters]",
"sentiment": 0.4019,
"highlighted_in": "main_text"
},
{
"highlight": "Albert Bourla, Chairman and CEO of <em>P[+186 characters]",
"sentiment": 0.743,
"highlighted_in": "main_text"
},
{
"highlight": "Explore the complete 8-K earnings releas[+63 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Pfizer</em> <em>Inc</em>. Reports Q1 2025 Earnings: EPS of $0.52 Beats Estimates, Revenue at $13.7 Billion Misses Expectations",
"sentiment": -0.2263,
"highlighted_in": "title"
}
]
}
],
"similar": []
},
{
"uuid": "2da770b2-d1e9-42d4-9c75-2560ea0727b4",
"title": "Pfizer Inc. (PFE) Files Form 8-K Report with SEC",
"description": "Pfizer Inc. (PFE) has recently filed a Form 8-K with the United States Securities and Exchange Commission (SEC), dated April 24, 2025. This filing is part of",
"keywords": "GuruFocus, Article, News, GuruFocus News, PFE",
"snippet": "Pfizer Inc. (PFE, Financial) has recently filed a Form 8-K with the United States Securities and Exchange Commission (SEC), dated April 24, 2025. This filing is...",
"url": "https://www.gurufocus.com/news/2811478/pfizer-inc-pfe-files-form-8k-report-with-sec",
"image_url": "https://static.gurufocus.com/logos/0C00000C7U.png?5",
"language": "en",
"published_at": "2025-04-29T13:30:17.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "PFECL.SN",
"name": "PFIZER INC",
"exchange": null,
"exchange_long": null,
"country": "cl",
"type": "equity",
"industry": "N/A",
"match_score": 71.08162,
"sentiment_score": 0.215775,
"highlights": [
{
"highlight": "<em>Pfizer</em> <em>Inc</em>. (PFE, Fina[+221 characters]",
"sentiment": 0.7351,
"highlighted_in": "main_text"
},
{
"highlight": "For more detailed insights and analysis [+322 characters]",
"sentiment": 0.128,
"highlighted_in": "main_text"
},
{
"highlight": "See the in-depth <em>Pfizer</em> <em>Inc[+32 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Pfizer</em> <em>Inc</em>. (PFE) Files Form 8-K Report with SEC",
"sentiment": 0,
"highlighted_in": "title"
}
]
},
{
"symbol": "PFE.SN",
"name": "Pfizer Inc.",
"exchange": null,
"exchange_long": null,
"country": "cl",
"type": "equity",
"industry": "Healthcare",
"match_score": 71.08162,
"sentiment_score": 0.215775,
"highlights": [
{
"highlight": "<em>Pfizer</em> <em>Inc</em>. (PFE, Fina[+221 characters]",
"sentiment": 0.7351,
"highlighted_in": "main_text"
},
{
"highlight": "For more detailed insights and analysis [+322 characters]",
"sentiment": 0.128,
"highlighted_in": "main_text"
},
{
"highlight": "See the in-depth <em>Pfizer</em> <em>Inc[+32 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Pfizer</em> <em>Inc</em>. (PFE) Files Form 8-K Report with SEC",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
],
"similar": [
{
"uuid": "450aa98a-cd49-4ce9-8202-42fbd0441933",
"title": "Pfizer (PFE) Maintains Strong Performance Despite Medicare Challenges | PFE Stock News",
"description": "Pfizer (PFE) has reported a robust performance in the first quarter, indicating the company's ongoing emphasis on effective sales strategies even in the face of",
"keywords": "GuruFocus, Article, News, GuruFocus News, PFE",
"snippet": "Pfizer (PFE, Financial) has reported a robust performance in the first quarter, indicating the company's ongoing emphasis on effective sales strategies even in ...",
"url": "https://www.gurufocus.com/news/2811348/pfizer-pfe-maintains-strong-performance-despite-medicare-challenges-pfe-stock-news",
"image_url": "https://static.gurufocus.com/logos/0C00000C7U.png?20",
"language": "en",
"published_at": "2025-04-29T13:01:07.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "PFED.BA",
"name": "PFIZER INC",
"exchange": null,
"exchange_long": null,
"country": "ar",
"type": "equity",
"industry": "N/A",
"match_score": 44.649292,
"sentiment_score": 0.458433,
"highlights": [
{
"highlight": "<em>Pfizer</em> (PFE, Financial) has rep[+317 characters]",
"sentiment": 0.8402,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+277 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+324 characters]",
"sentiment": 0.5106,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+235 characters]",
"sentiment": 0.8176,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+233 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Positive Points\n\n<em>Pfizer</em> <em>Inc[+219 characters]",
"sentiment": 0.9136,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Pfizer</em> <em>Inc</em> (PFE) maint[+231 characters]",
"sentiment": 0.7184,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Pfizer</em> <em>Inc</em> (PFE) achie[+111 characters]",
"sentiment": 0.1027,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Pfizer</em> (PFE) Maintains Strong Performance Despite Medicare Challenges | PFE Stock News",
"sentiment": 0.496,
"highlighted_in": "title"
}
]
},
{
"symbol": "PFECL.SN",
"name": "PFIZER INC",
"exchange": null,
"exchange_long": null,
"country": "cl",
"type": "equity",
"industry": "N/A",
"match_score": 44.646805,
"sentiment_score": 0.458433,
"highlights": [
{
"highlight": "<em>Pfizer</em> (PFE, Financial) has rep[+317 characters]",
"sentiment": 0.8402,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+277 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+324 characters]",
"sentiment": 0.5106,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+235 characters]",
"sentiment": 0.8176,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+233 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Positive Points\n\n<em>Pfizer</em> <em>Inc[+219 characters]",
"sentiment": 0.9136,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Pfizer</em> <em>Inc</em> (PFE) maint[+231 characters]",
"sentiment": 0.7184,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Pfizer</em> <em>Inc</em> (PFE) achie[+111 characters]",
"sentiment": 0.1027,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Pfizer</em> (PFE) Maintains Strong Performance Despite Medicare Challenges | PFE Stock News",
"sentiment": 0.496,
"highlighted_in": "title"
}
]
},
{
"symbol": "PFE.SN",
"name": "Pfizer Inc.",
"exchange": null,
"exchange_long": null,
"country": "cl",
"type": "equity",
"industry": "Healthcare",
"match_score": 44.646805,
"sentiment_score": 0.458433,
"highlights": [
{
"highlight": "<em>Pfizer</em> (PFE, Financial) has rep[+317 characters]",
"sentiment": 0.8402,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+277 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+324 characters]",
"sentiment": 0.5106,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+235 characters]",
"sentiment": 0.8176,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+233 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Positive Points\n\n<em>Pfizer</em> <em>Inc[+219 characters]",
"sentiment": 0.9136,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Pfizer</em> <em>Inc</em> (PFE) maint[+231 characters]",
"sentiment": 0.7184,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Pfizer</em> <em>Inc</em> (PFE) achie[+111 characters]",
"sentiment": 0.1027,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Pfizer</em> (PFE) Maintains Strong Performance Despite Medicare Challenges | PFE Stock News",
"sentiment": 0.496,
"highlighted_in": "title"
}
]
},
{
"symbol": "PFE",
"name": "Pfizer Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 44.63952,
"sentiment_score": 0.458433,
"highlights": [
{
"highlight": "<em>Pfizer</em> (PFE, Financial) has rep[+317 characters]",
"sentiment": 0.8402,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+277 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+324 characters]",
"sentiment": 0.5106,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+235 characters]",
"sentiment": 0.8176,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+233 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Positive Points\n\n<em>Pfizer</em> <em>Inc[+219 characters]",
"sentiment": 0.9136,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Pfizer</em> <em>Inc</em> (PFE) maint[+231 characters]",
"sentiment": 0.7184,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Pfizer</em> <em>Inc</em> (PFE) achie[+111 characters]",
"sentiment": 0.1027,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Pfizer</em> (PFE) Maintains Strong Performance Despite Medicare Challenges | PFE Stock News",
"sentiment": 0.496,
"highlighted_in": "title"
}
]
},
{
"symbol": "PFE-WI",
"name": "Pfizer, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "N/A",
"match_score": 44.63952,
"sentiment_score": 0.458433,
"highlights": [
{
"highlight": "<em>Pfizer</em> (PFE, Financial) has rep[+317 characters]",
"sentiment": 0.8402,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+277 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+324 characters]",
"sentiment": 0.5106,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+235 characters]",
"sentiment": 0.8176,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+233 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Positive Points\n\n<em>Pfizer</em> <em>Inc[+219 characters]",
"sentiment": 0.9136,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Pfizer</em> <em>Inc</em> (PFE) maint[+231 characters]",
"sentiment": 0.7184,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Pfizer</em> <em>Inc</em> (PFE) achie[+111 characters]",
"sentiment": 0.1027,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Pfizer</em> (PFE) Maintains Strong Performance Despite Medicare Challenges | PFE Stock News",
"sentiment": 0.496,
"highlighted_in": "title"
}
]
}
]
},
{
"uuid": "ab3533ea-5b3e-4b95-ac93-41c0a22e0cbb",
"title": "Pfizer (PFE) Surpasses EPS Expectations but Misses Revenue Target",
"description": "Key Takeaways:\n Pfizer (PFE) surpassed earnings forecasts with a non-GAAP EPS of $0.92, but missed revenue targets. Analysts project an average potential",
"keywords": "GuruFocus, Article, News, GuruFocus News, PFE",
"snippet": "Key Takeaways:\n\nPfizer (PFE, Financial) surpassed earnings forecasts with a non-GAAP EPS of $0.92, but missed revenue targets.\n\nAnalysts project an average pote...",
"url": "https://www.gurufocus.com/news/2811345/pfizer-pfe-surpasses-eps-expectations-but-misses-revenue-target",
"image_url": "https://static.gurufocus.com/logos/0C00000C7U.png?20",
"language": "en",
"published_at": "2025-04-29T13:00:56.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "PFED.BA",
"name": "PFIZER INC",
"exchange": null,
"exchange_long": null,
"country": "ar",
"type": "equity",
"industry": "N/A",
"match_score": 47.20102,
"sentiment_score": 0.049414,
"highlights": [
{
"highlight": "Key Takeaways:\n\n<em>Pfizer</em> (PFE, Fi[+212 characters]",
"sentiment": -0.4215,
"highlighted_in": "main_text"
},
{
"highlight": "Pfizer's Earnings Performance\n\n<em>Pfize[+233 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts' Forecast\n\nIn evalu[+326 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "For a deeper dive into these projections[+315 characters]",
"sentiment": 0.5106,
"highlighted_in": "main_text"
},
{
"highlight": "GuruFocus GF Value Assessment\n\nAccording[+204 characters]",
"sentiment": 0.5859,
"highlighted_in": "main_text"
},
{
"highlight": "For more extensive details, explore the [+48 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Pfizer</em> (PFE) Surpasses EPS Expectations but Misses Revenue Target",
"sentiment": -0.3291,
"highlighted_in": "title"
}
]
},
{
"symbol": "PFECL.SN",
"name": "PFIZER INC",
"exchange": null,
"exchange_long": null,
"country": "cl",
"type": "equity",
"industry": "N/A",
"match_score": 47.19837,
"sentiment_score": 0.049414,
"highlights": [
{
"highlight": "Key Takeaways:\n\n<em>Pfizer</em> (PFE, Fi[+212 characters]",
"sentiment": -0.4215,
"highlighted_in": "main_text"
},
{
"highlight": "Pfizer's Earnings Performance\n\n<em>Pfize[+233 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts' Forecast\n\nIn evalu[+326 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "For a deeper dive into these projections[+315 characters]",
"sentiment": 0.5106,
"highlighted_in": "main_text"
},
{
"highlight": "GuruFocus GF Value Assessment\n\nAccording[+204 characters]",
"sentiment": 0.5859,
"highlighted_in": "main_text"
},
{
"highlight": "For more extensive details, explore the [+48 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Pfizer</em> (PFE) Surpasses EPS Expectations but Misses Revenue Target",
"sentiment": -0.3291,
"highlighted_in": "title"
}
]
},
{
"symbol": "PFE.SN",
"name": "Pfizer Inc.",
"exchange": null,
"exchange_long": null,
"country": "cl",
"type": "equity",
"industry": "Healthcare",
"match_score": 47.19837,
"sentiment_score": 0.049414,
"highlights": [
{
"highlight": "Key Takeaways:\n\n<em>Pfizer</em> (PFE, Fi[+212 characters]",
"sentiment": -0.4215,
"highlighted_in": "main_text"
},
{
"highlight": "Pfizer's Earnings Performance\n\n<em>Pfize[+233 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts' Forecast\n\nIn evalu[+326 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "For a deeper dive into these projections[+315 characters]",
"sentiment": 0.5106,
"highlighted_in": "main_text"
},
{
"highlight": "GuruFocus GF Value Assessment\n\nAccording[+204 characters]",
"sentiment": 0.5859,
"highlighted_in": "main_text"
},
{
"highlight": "For more extensive details, explore the [+48 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Pfizer</em> (PFE) Surpasses EPS Expectations but Misses Revenue Target",
"sentiment": -0.3291,
"highlighted_in": "title"
}
]
},
{
"symbol": "PFE",
"name": "Pfizer Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 47.190525,
"sentiment_score": 0.049414,
"highlights": [
{
"highlight": "Key Takeaways:\n\n<em>Pfizer</em> (PFE, Fi[+212 characters]",
"sentiment": -0.4215,
"highlighted_in": "main_text"
},
{
"highlight": "Pfizer's Earnings Performance\n\n<em>Pfize[+233 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts' Forecast\n\nIn evalu[+326 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "For a deeper dive into these projections[+315 characters]",
"sentiment": 0.5106,
"highlighted_in": "main_text"
},
{
"highlight": "GuruFocus GF Value Assessment\n\nAccording[+204 characters]",
"sentiment": 0.5859,
"highlighted_in": "main_text"
},
{
"highlight": "For more extensive details, explore the [+48 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Pfizer</em> (PFE) Surpasses EPS Expectations but Misses Revenue Target",
"sentiment": -0.3291,
"highlighted_in": "title"
}
]
},
{
"symbol": "PFE-WI",
"name": "Pfizer, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "N/A",
"match_score": 47.190525,
"sentiment_score": 0.049414,
"highlights": [
{
"highlight": "Key Takeaways:\n\n<em>Pfizer</em> (PFE, Fi[+212 characters]",
"sentiment": -0.4215,
"highlighted_in": "main_text"
},
{
"highlight": "Pfizer's Earnings Performance\n\n<em>Pfize[+233 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts' Forecast\n\nIn evalu[+326 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "For a deeper dive into these projections[+315 characters]",
"sentiment": 0.5106,
"highlighted_in": "main_text"
},
{
"highlight": "GuruFocus GF Value Assessment\n\nAccording[+204 characters]",
"sentiment": 0.5859,
"highlighted_in": "main_text"
},
{
"highlight": "For more extensive details, explore the [+48 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Pfizer</em> (PFE) Surpasses EPS Expectations but Misses Revenue Target",
"sentiment": -0.3291,
"highlighted_in": "title"
}
]
}
]
},
{
"uuid": "6237f45a-ad69-4e51-8d26-0853170d7c0f",
"title": "Pfizer (PFE) Eyes Acquisitions After Q1 2025 Results",
"description": "Key Takeaways:\n Pfizer's strategic focus on acquisitions aims to boost its cardiometabolic offerings. Analysts suggest an average upside potential of over",
"keywords": "GuruFocus, Article, News, GuruFocus News, PFE",
"snippet": "Key Takeaways:\n\nPfizer's strategic focus on acquisitions aims to boost its cardiometabolic offerings.\n\nAnalysts suggest an average upside potential of over 24% ...",
"url": "https://www.gurufocus.com/news/2811179/pfizer-pfe-eyes-acquisitions-after-q1-2025-results",
"image_url": "https://static.gurufocus.com/logos/0C00000C7U.png?20",
"language": "en",
"published_at": "2025-04-29T12:58:53.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "PFED.BA",
"name": "PFIZER INC",
"exchange": null,
"exchange_long": null,
"country": "ar",
"type": "equity",
"industry": "N/A",
"match_score": 48.814934,
"sentiment_score": 0.20712,
"highlights": [
{
"highlight": "Analysts suggest an average upside poten[+334 characters]",
"sentiment": 0.2987,
"highlighted_in": "main_text"
},
{
"highlight": "However, <em>Pfizer</em> surprised the m[+260 characters]",
"sentiment": 0.2263,
"highlighted_in": "main_text"
},
{
"highlight": "For more in-depth estimates, visit the <[+347 characters]",
"sentiment": 0.5106,
"highlighted_in": "main_text"
},
{
"highlight": "For detailed data, refer to the <em>Pfiz[+40 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Pfizer</em> (PFE) Eyes Acquisitions After Q1 2025 Results",
"sentiment": 0,
"highlighted_in": "title"
}
]
},
{
"symbol": "PFECL.SN",
"name": "PFIZER INC",
"exchange": null,
"exchange_long": null,
"country": "cl",
"type": "equity",
"industry": "N/A",
"match_score": 48.812187,
"sentiment_score": 0.20712,
"highlights": [
{
"highlight": "Analysts suggest an average upside poten[+334 characters]",
"sentiment": 0.2987,
"highlighted_in": "main_text"
},
{
"highlight": "However, <em>Pfizer</em> surprised the m[+260 characters]",
"sentiment": 0.2263,
"highlighted_in": "main_text"
},
{
"highlight": "For more in-depth estimates, visit the <[+347 characters]",
"sentiment": 0.5106,
"highlighted_in": "main_text"
},
{
"highlight": "For detailed data, refer to the <em>Pfiz[+40 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Pfizer</em> (PFE) Eyes Acquisitions After Q1 2025 Results",
"sentiment": 0,
"highlighted_in": "title"
}
]
},
{
"symbol": "PFE.SN",
"name": "Pfizer Inc.",
"exchange": null,
"exchange_long": null,
"country": "cl",
"type": "equity",
"industry": "Healthcare",
"match_score": 48.812187,
"sentiment_score": 0.20712,
"highlights": [
{
"highlight": "Analysts suggest an average upside poten[+334 characters]",
"sentiment": 0.2987,
"highlighted_in": "main_text"
},
{
"highlight": "However, <em>Pfizer</em> surprised the m[+260 characters]",
"sentiment": 0.2263,
"highlighted_in": "main_text"
},
{
"highlight": "For more in-depth estimates, visit the <[+347 characters]",
"sentiment": 0.5106,
"highlighted_in": "main_text"
},
{
"highlight": "For detailed data, refer to the <em>Pfiz[+40 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Pfizer</em> (PFE) Eyes Acquisitions After Q1 2025 Results",
"sentiment": 0,
"highlighted_in": "title"
}
]
},
{
"symbol": "PFE",
"name": "Pfizer Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 69.53183,
"sentiment_score": 0.20712,
"highlights": [
{
"highlight": "Analysts suggest an average upside poten[+352 characters]",
"sentiment": 0.2987,
"highlighted_in": "main_text"
},
{
"highlight": "However, <em>Pfizer</em> surprised the m[+260 characters]",
"sentiment": 0.2263,
"highlighted_in": "main_text"
},
{
"highlight": "For more in-depth estimates, visit the <[+347 characters]",
"sentiment": 0.5106,
"highlighted_in": "main_text"
},
{
"highlight": "For detailed data, refer to the <em>Pfiz[+40 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Pfizer</em> (PFE) Eyes Acquisitions After Q1 2025 Results",
"sentiment": 0,
"highlighted_in": "title"
}
]
},
{
"symbol": "PFE-WI",
"name": "Pfizer, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "N/A",
"match_score": 54.218124,
"sentiment_score": 0.20712,
"highlights": [
{
"highlight": "Analysts suggest an average upside poten[+334 characters]",
"sentiment": 0.2987,
"highlighted_in": "main_text"
},
{
"highlight": "However, <em>Pfizer</em> surprised the m[+260 characters]",
"sentiment": 0.2263,
"highlighted_in": "main_text"
},
{
"highlight": "For more in-depth estimates, visit the <[+347 characters]",
"sentiment": 0.5106,
"highlighted_in": "main_text"
},
{
"highlight": "For detailed data, refer to the <em>Pfiz[+40 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Pfizer</em> (PFE) Eyes Acquisitions After Q1 2025 Results",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
]
}
]
},
{
"uuid": "aeb6873c-f95f-4815-b612-3d549df6be0c",
"title": "Domino's Pizza (DPZ) Price Target Raised by Morgan Stanley | DPZ Stock News",
"description": "Morgan Stanley, with Brian Harbour as the analyst, has increased its price target for Domino's Pizza (DPZ) to $510, up from $492, while maintaining an Overweigh",
"keywords": "GuruFocus, Article, News, GuruFocus News, DPZ",
"snippet": "Morgan Stanley, with Brian Harbour as the analyst, has increased its price target for Domino’s Pizza (DPZ, Financial) to $510, up from $492, while maintaining...",
"url": "https://www.gurufocus.com/news/2811449/dominos-pizza-dpz-price-target-raised-by-morgan-stanley-dpz-stock-news",
"image_url": "https://static.gurufocus.com/logos/0C00000AZX.png?20",
"language": "en",
"published_at": "2025-04-29T13:20:36.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "MSCL.SN",
"name": "MORGAN STANLEY",
"exchange": null,
"exchange_long": null,
"country": "cl",
"type": "equity",
"industry": "N/A",
"match_score": 91.99535,
"sentiment_score": 0.3701,
"highlights": [
{
"highlight": "<em>Morgan</em> <em>Stanley</em>, with B[+319 characters]",
"sentiment": 0.7402,
"highlighted_in": "main_text"
},
{
"highlight": "Domino's Pizza (DPZ) Price Target Raised by <em>Morgan</em> <em>Stanley</em> | DPZ Stock News",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
],
"similar": []
},
{
"uuid": "f0c046aa-679f-411b-a20d-3f868983b838",
"title": "Novavax Appoints Charles Newton to Board of Directors | NVAX Stock News",
"description": "Novavax (NVAX) appoints Charles Newton to its Board of Directors as an independent director. Newton's appointment aligns with Novavax's growth strategy",
"keywords": "GuruFocus, Article, News, GuruFocus News, NVAX",
"snippet": "Novavax (NVAX, Financial) appoints Charles Newton to its Board of Directors as an independent director.\n\nNewton's appointment aligns with Novavax’s growth str...",
"url": "https://www.gurufocus.com/news/2811444/novavax-appoints-charles-newton-to-board-of-directors-nvax-stock-news",
"image_url": "https://static.gurufocus.com/logos/0C00000BWN.png?20",
"language": "en",
"published_at": "2025-04-29T13:20:12.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "MSCL.SN",
"name": "MORGAN STANLEY",
"exchange": null,
"exchange_long": null,
"country": "cl",
"type": "equity",
"industry": "N/A",
"match_score": 26.109592,
"sentiment_score": 0.5267,
"highlights": [
{
"highlight": "Currently serving as the Chief Financial[+283 characters]",
"sentiment": 0.5267,
"highlighted_in": "main_text"
}
]
}
],
"similar": [
{
"uuid": "725f66e7-7da8-43ed-bdc1-0c565f403418",
"title": "Novavax (NVAX) Welcomes Charles Newton to Board of Directors | NVAX Stock News",
"description": "Novavax, trading under the ticker NVAX, has appointed Charles Newton as an independent director to its board. Newton brings a wealth of experience from his back",
"keywords": "GuruFocus, Article, News, GuruFocus News, NVAX",
"snippet": "Novavax, trading under the ticker NVAX, has appointed Charles Newton as an independent director to its board. Newton brings a wealth of experience from his back...",
"url": "https://www.gurufocus.com/news/2811427/novavax-nvax-welcomes-charles-newton-to-board-of-directors-nvax-stock-news",
"image_url": "https://static.gurufocus.com/logos/0C00000BWN.png?20",
"language": "en",
"published_at": "2025-04-29T13:19:08.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "MSCL.SN",
"name": "MORGAN STANLEY",
"exchange": null,
"exchange_long": null,
"country": "cl",
"type": "equity",
"industry": "N/A",
"match_score": 19.116457,
"sentiment_score": 0.3818,
"highlights": [
{
"highlight": "Previously, Newton held leadership roles[+143 characters]",
"sentiment": 0.3818,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "NVAX",
"name": "Novavax, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 52.53225,
"sentiment_score": 0.196411,
"highlights": [
{
"highlight": "<em>Novavax</em>, trading under the tick[+251 characters]",
"sentiment": 0.4939,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+277 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+333 characters]",
"sentiment": 0.5106,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+238 characters]",
"sentiment": 0.7579,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+274 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Positive Points\n\n<em>Novavax</em> <em>In[+195 characters]",
"sentiment": 0.5574,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Novavax</em> <em>Inc</em> (NVAX) ini[+280 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Novavax</em> <em>Inc</em> (NVAX) is [+194 characters]",
"sentiment": -0.6808,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Novavax</em> (NVAX) Welcomes Charles Newton to Board of Directors | NVAX Stock News",
"sentiment": 0.4019,
"highlighted_in": "title"
}
]
}
]
}
]
},
{
"uuid": "a1c380a8-e639-48f4-87be-744cf1d18e2b",
"title": "Amkor Technology (AMKR) Sees Price Target Cut by Morgan Stanley | AMKR Stock News",
"description": "Morgan Stanley has adjusted its price target for Amkor Technology (AMKR), reducing it from $24 to $19. The financial institution maintains an \"Equal Weight\" sta",
"keywords": "GuruFocus, Article, News, GuruFocus News, AMKR",
"snippet": "Morgan Stanley has adjusted its price target for Amkor Technology (AMKR, Financial), reducing it from $24 to $19. The financial institution maintains an \"Equal ...",
"url": "https://www.gurufocus.com/news/2811379/amkor-technology-amkr-sees-price-target-cut-by-morgan-stanley-amkr-stock-news",
"image_url": "https://static.gurufocus.com/images/global_logo_twitter_card.png",
"language": "en",
"published_at": "2025-04-29T13:15:31.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "MSCL.SN",
"name": "MORGAN STANLEY",
"exchange": null,
"exchange_long": null,
"country": "cl",
"type": "equity",
"industry": "N/A",
"match_score": 89.06227,
"sentiment_score": -0.194267,
"highlights": [
{
"highlight": "<em>Morgan</em> <em>Stanley</em> has adj[+276 characters]",
"sentiment": 0.0516,
"highlighted_in": "main_text"
},
{
"highlight": "As a result, <em>Morgan</em> <em>Stanley[+292 characters]",
"sentiment": -0.3612,
"highlighted_in": "main_text"
},
{
"highlight": "Amkor Technology (AMKR) Sees Price Target Cut by <em>Morgan</em> <em>Stanley</em> | AMKR Stock News",
"sentiment": -0.2732,
"highlighted_in": "title"
}
]
}
],
"similar": []
},
{
"uuid": "4fe12be0-9b05-4243-9003-8e3018ead659",
"title": "Progressive (PGR) Sees Price Target Boost and Positive Outlook | PGR Stock News",
"description": "Morgan Stanley has elevated its price target for Progressive (PGR) from $310 to $320 while maintaining an Overweight rating. The firm anticipates that the compa",
"keywords": "GuruFocus, Article, News, GuruFocus News, PGR",
"snippet": "Morgan Stanley has elevated its price target for Progressive (PGR, Financial) from $310 to $320 while maintaining an Overweight rating. The firm anticipates tha...",
"url": "https://www.gurufocus.com/news/2811357/progressive-pgr-sees-price-target-boost-and-positive-outlook-pgr-stock-news",
"image_url": "https://static.gurufocus.com/logos/0C000008LU.png?20",
"language": "en",
"published_at": "2025-04-29T13:02:00.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "MSCL.SN",
"name": "MORGAN STANLEY",
"exchange": null,
"exchange_long": null,
"country": "cl",
"type": "equity",
"industry": "N/A",
"match_score": 20.082754,
"sentiment_score": -0.34,
"highlights": [
{
"highlight": "<em>Morgan</em> <em>Stanley</em> has ele[+259 characters]",
"sentiment": -0.34,
"highlighted_in": "main_text"
}
]
}
],
"similar": []
},
{
"uuid": "1ececc7d-2ccb-4d36-b1b8-3c3bb2383664",
"title": "Pfizer (PFE) Surpasses EPS Expectations, Revenue Falls Short",
"description": "Key Takeaways:\n Pfizer (PFE) surpassed earnings expectations but faced a revenue miss. The stock offers a competitive 7.5% dividend yield, appealing to in",
"keywords": "GuruFocus, Article, News, GuruFocus News, PFE",
"snippet": "Key Takeaways:\n\nPfizer (PFE, Financial) surpassed earnings expectations but faced a revenue miss.\n\nThe stock offers a competitive 7.5% dividend yield, appealing...",
"url": "https://www.gurufocus.com/news/2811354/pfizer-pfe-surpasses-eps-expectations-revenue-falls-short",
"image_url": "https://static.gurufocus.com/logos/0C00000C7U.png?20",
"language": "en",
"published_at": "2025-04-29T13:01:37.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "PFECL.SN",
"name": "PFIZER INC",
"exchange": null,
"exchange_long": null,
"country": "cl",
"type": "equity",
"industry": "N/A",
"match_score": 48.088676,
"sentiment_score": 0.297186,
"highlights": [
{
"highlight": "Key Takeaways:\n\n<em>Pfizer</em> (PFE, Fi[+270 characters]",
"sentiment": 0.0387,
"highlighted_in": "main_text"
},
{
"highlight": "Nevertheless, <em>Pfizer</em> continues [+276 characters]",
"sentiment": 0.8126,
"highlighted_in": "main_text"
},
{
"highlight": "Based on the one-year price targets prov[+206 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "For a more detailed analysis, visit the [+278 characters]",
"sentiment": 0.5106,
"highlighted_in": "main_text"
},
{
"highlight": "Assessing Pfizer's GF Value\n\nUsing the p[+236 characters]",
"sentiment": 0.7184,
"highlighted_in": "main_text"
},
{
"highlight": "For an in-depth valuation analysis, acce[+55 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Pfizer</em> (PFE) Surpasses EPS Expectations, Revenue Falls Short",
"sentiment": 0,
"highlighted_in": "title"
}
]
},
{
"symbol": "PFE.SN",
"name": "Pfizer Inc.",
"exchange": null,
"exchange_long": null,
"country": "cl",
"type": "equity",
"industry": "Healthcare",
"match_score": 48.088676,
"sentiment_score": 0.297186,
"highlights": [
{
"highlight": "Key Takeaways:\n\n<em>Pfizer</em> (PFE, Fi[+270 characters]",
"sentiment": 0.0387,
"highlighted_in": "main_text"
},
{
"highlight": "Nevertheless, <em>Pfizer</em> continues [+276 characters]",
"sentiment": 0.8126,
"highlighted_in": "main_text"
},
{
"highlight": "Based on the one-year price targets prov[+206 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "For a more detailed analysis, visit the [+278 characters]",
"sentiment": 0.5106,
"highlighted_in": "main_text"
},
{
"highlight": "Assessing Pfizer's GF Value\n\nUsing the p[+236 characters]",
"sentiment": 0.7184,
"highlighted_in": "main_text"
},
{
"highlight": "For an in-depth valuation analysis, acce[+55 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Pfizer</em> (PFE) Surpasses EPS Expectations, Revenue Falls Short",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
],
"similar": [
{
"uuid": "137fc841-f2fb-4034-bed7-5b3867a11102",
"title": "Pfizer (PFE) Q1 Revenue Falls Short of Expectations | PFE Stock News",
"description": "Pfizer (PFE) announced its first-quarter revenue, totaling $13.7 billion, which fell short of the anticipated $14.09 billion according to consensus estimates. D",
"keywords": "GuruFocus, Article, News, GuruFocus News, PFE",
"snippet": "Pfizer (PFE, Financial) announced its first-quarter revenue, totaling $13.7 billion, which fell short of the anticipated $14.09 billion according to consensus e...",
"url": "https://www.gurufocus.com/news/2811012/pfizer-pfe-q1-revenue-falls-short-of-expectations-pfe-stock-news",
"image_url": "https://static.gurufocus.com/logos/0C00000C7U.png?20",
"language": "en",
"published_at": "2025-04-29T12:25:31.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "PFED.BA",
"name": "PFIZER INC",
"exchange": null,
"exchange_long": null,
"country": "ar",
"type": "equity",
"industry": "N/A",
"match_score": 44.649292,
"sentiment_score": 0.3842,
"highlights": [
{
"highlight": "<em>Pfizer</em> (PFE, Financial) announc[+239 characters]",
"sentiment": 0.3818,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Pfizer</em> remains confident in its[+111 characters]",
"sentiment": 0.6705,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+277 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+324 characters]",
"sentiment": 0.5106,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+235 characters]",
"sentiment": 0.8176,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+233 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Positive Points\n\n<em>Pfizer</em> <em>Inc[+219 characters]",
"sentiment": 0.9136,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Pfizer</em> <em>Inc</em> (PFE) maint[+231 characters]",
"sentiment": 0.7184,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Pfizer</em> <em>Inc</em> (PFE) achie[+111 characters]",
"sentiment": 0.1027,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Pfizer</em> (PFE) Q1 Revenue Falls Short of Expectations | PFE Stock News",
"sentiment": 0,
"highlighted_in": "title"
}
]
},
{
"symbol": "PFECL.SN",
"name": "PFIZER INC",
"exchange": null,
"exchange_long": null,
"country": "cl",
"type": "equity",
"industry": "N/A",
"match_score": 44.646805,
"sentiment_score": 0.3842,
"highlights": [
{
"highlight": "<em>Pfizer</em> (PFE, Financial) announc[+239 characters]",
"sentiment": 0.3818,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Pfizer</em> remains confident in its[+111 characters]",
"sentiment": 0.6705,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+277 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+324 characters]",
"sentiment": 0.5106,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+235 characters]",
"sentiment": 0.8176,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+233 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Positive Points\n\n<em>Pfizer</em> <em>Inc[+219 characters]",
"sentiment": 0.9136,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Pfizer</em> <em>Inc</em> (PFE) maint[+231 characters]",
"sentiment": 0.7184,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Pfizer</em> <em>Inc</em> (PFE) achie[+111 characters]",
"sentiment": 0.1027,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Pfizer</em> (PFE) Q1 Revenue Falls Short of Expectations | PFE Stock News",
"sentiment": 0,
"highlighted_in": "title"
}
]
},
{
"symbol": "PFE.SN",
"name": "Pfizer Inc.",
"exchange": null,
"exchange_long": null,
"country": "cl",
"type": "equity",
"industry": "Healthcare",
"match_score": 44.646805,
"sentiment_score": 0.3842,
"highlights": [
{
"highlight": "<em>Pfizer</em> (PFE, Financial) announc[+239 characters]",
"sentiment": 0.3818,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Pfizer</em> remains confident in its[+111 characters]",
"sentiment": 0.6705,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+277 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+324 characters]",
"sentiment": 0.5106,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+235 characters]",
"sentiment": 0.8176,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+233 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Positive Points\n\n<em>Pfizer</em> <em>Inc[+219 characters]",
"sentiment": 0.9136,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Pfizer</em> <em>Inc</em> (PFE) maint[+231 characters]",
"sentiment": 0.7184,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Pfizer</em> <em>Inc</em> (PFE) achie[+111 characters]",
"sentiment": 0.1027,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Pfizer</em> (PFE) Q1 Revenue Falls Short of Expectations | PFE Stock News",
"sentiment": 0,
"highlighted_in": "title"
}
]
},
{
"symbol": "PFE",
"name": "Pfizer Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 44.63952,
"sentiment_score": 0.3842,
"highlights": [
{
"highlight": "<em>Pfizer</em> (PFE, Financial) announc[+239 characters]",
"sentiment": 0.3818,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Pfizer</em> remains confident in its[+111 characters]",
"sentiment": 0.6705,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+277 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+324 characters]",
"sentiment": 0.5106,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+235 characters]",
"sentiment": 0.8176,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+233 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Positive Points\n\n<em>Pfizer</em> <em>Inc[+219 characters]",
"sentiment": 0.9136,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Pfizer</em> <em>Inc</em> (PFE) maint[+231 characters]",
"sentiment": 0.7184,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Pfizer</em> <em>Inc</em> (PFE) achie[+111 characters]",
"sentiment": 0.1027,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Pfizer</em> (PFE) Q1 Revenue Falls Short of Expectations | PFE Stock News",
"sentiment": 0,
"highlighted_in": "title"
}
]
},
{
"symbol": "PFE-WI",
"name": "Pfizer, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "N/A",
"match_score": 44.63952,
"sentiment_score": 0.3842,
"highlights": [
{
"highlight": "<em>Pfizer</em> (PFE, Financial) announc[+239 characters]",
"sentiment": 0.3818,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Pfizer</em> remains confident in its[+111 characters]",
"sentiment": 0.6705,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+277 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+324 characters]",
"sentiment": 0.5106,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+235 characters]",
"sentiment": 0.8176,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+233 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Positive Points\n\n<em>Pfizer</em> <em>Inc[+219 characters]",
"sentiment": 0.9136,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Pfizer</em> <em>Inc</em> (PFE) maint[+231 characters]",
"sentiment": 0.7184,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Pfizer</em> <em>Inc</em> (PFE) achie[+111 characters]",
"sentiment": 0.1027,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Pfizer</em> (PFE) Q1 Revenue Falls Short of Expectations | PFE Stock News",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
]
}
]
},
{
"uuid": "46051a44-d1d0-4d1c-94c3-1e976ed1c167",
"title": "F5 Networks (FFIV) Receives Price Target Boost Amid Strong Systems Revenue | FFIV Stock News",
"description": "F5 Networks, traded under the ticker FFIV, has seen its price target increased by Morgan Stanley from $269 to $280, while maintaining an Equal Weight rating. Th",
"keywords": "GuruFocus, Article, News, GuruFocus News, FFIV",
"snippet": "F5 Networks, traded under the ticker FFIV, has seen its price target increased by Morgan Stanley from $269 to $280, while maintaining an Equal Weight rating. Th...",
"url": "https://www.gurufocus.com/news/2811353/f5-networks-ffiv-receives-price-target-boost-amid-strong-systems-revenue-ffiv-stock-news",
"image_url": "https://static.gurufocus.com/logos/0C000007K3.png?20",
"language": "en",
"published_at": "2025-04-29T13:01:36.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "MSCL.SN",
"name": "MORGAN STANLEY",
"exchange": null,
"exchange_long": null,
"country": "cl",
"type": "equity",
"industry": "N/A",
"match_score": 25.069698,
"sentiment_score": 0.15985,
"highlights": [
{
"highlight": "F5 Networks, traded under the ticker FFI[+304 characters]",
"sentiment": 0.6597,
"highlighted_in": "main_text"
},
{
"highlight": "Despite this positive development, <em>M[+250 characters]",
"sentiment": -0.34,
"highlighted_in": "main_text"
}
]
}
],
"similar": []
},
{
"uuid": "06f8a78f-affa-4d2a-9596-7a478b32e1ca",
"title": "Coca-Cola (KO) Surpasses Sales Expectations in Q1",
"description": "Coca-Cola (KO) stock climbs as Q1 results exceed expectations. Wall Street analysts project a potential upside of 5.53% for KO shares. GuruFocus esti",
"keywords": "GuruFocus, Article, News, GuruFocus News, KO",
"snippet": "Coca-Cola (KO, Financial) stock climbs as Q1 results exceed expectations.\n\nWall Street analysts project a potential upside of 5.53% for KO shares.\n\nGuruFocus es...",
"url": "https://www.gurufocus.com/news/2811183/cocacola-ko-surpasses-sales-expectations-in-q1",
"image_url": "https://static.gurufocus.com/logos/0C00000ALB.png?20",
"language": "en",
"published_at": "2025-04-29T13:00:00.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "KOCL.SN",
"name": "COCA-COLA CO",
"exchange": null,
"exchange_long": null,
"country": "cl",
"type": "equity",
"industry": "N/A",
"match_score": 90.24087,
"sentiment_score": 0.441525,
"highlights": [
{
"highlight": "<em>Coca</em>-<em>Cola</em> (KO, Financi[+193 characters]",
"sentiment": 0.0516,
"highlighted_in": "main_text"
},
{
"highlight": "The beverage giant <em>Coca</em>-<em>Col[+322 characters]",
"sentiment": 0.7269,
"highlighted_in": "main_text"
},
{
"highlight": "Nevertheless, <em>Coca</em>-<em>Cola</em[+220 characters]",
"sentiment": 0.802,
"highlighted_in": "main_text"
},
{
"highlight": "Evaluating the company’s prospects, 25[+298 characters]",
"sentiment": 0.3612,
"highlighted_in": "main_text"
},
{
"highlight": "For detailed insights, please visit the [+305 characters]",
"sentiment": 0.6808,
"highlighted_in": "main_text"
},
{
"highlight": "The estimated GF Value for <em>Coca</em>[+288 characters]",
"sentiment": 0.6597,
"highlighted_in": "main_text"
},
{
"highlight": "For comprehensive data and further evalu[+75 characters]",
"sentiment": 0.25,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Coca</em>-<em>Cola</em> (KO) Surpasses Sales Expectations in Q1",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
],
"similar": [
{
"uuid": "1c6a22fa-135f-4b38-b2e0-29d40a32d3b3",
"title": "Honeywell (HON) Surpasses Q1 Expectations with Robust Earnings",
"description": "Honeywell International (HON) surpasses earnings and revenue expectations in Q1. Average analyst price target suggests a potential 15.40% upside. Cur",
"keywords": "GuruFocus, Article, News, GuruFocus News, HON",
"snippet": "Honeywell International (HON, Financial) surpasses earnings and revenue expectations in Q1.\n\nAverage analyst price target suggests a potential 15.40% upside.\n\nC...",
"url": "https://www.gurufocus.com/news/2810816/honeywell-hon-surpasses-q1-expectations-with-robust-earnings",
"image_url": "https://static.gurufocus.com/logos/0C00000BBJ.png?20",
"language": "en",
"published_at": "2025-04-29T12:01:36.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "HON.SN",
"name": "Honeywell International Inc.",
"exchange": null,
"exchange_long": null,
"country": "cl",
"type": "equity",
"industry": "Industrials",
"match_score": 50.09387,
"sentiment_score": 0.37958,
"highlights": [
{
"highlight": "<em>Honeywell</em> <em>International</em[+332 characters]",
"sentiment": 0.7783,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nAccording[+319 characters]",
"sentiment": 0.0516,
"highlighted_in": "main_text"
},
{
"highlight": "Detailed estimate data is available on t[+313 characters]",
"sentiment": 0.5106,
"highlighted_in": "main_text"
},
{
"highlight": "Using the proprietary metrics from GuruF[+242 characters]",
"sentiment": 0.5574,
"highlighted_in": "main_text"
},
{
"highlight": "Further details are provided on the <em>[+70 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "HON",
"name": "Honeywell International Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Industrials",
"match_score": 50.095802,
"sentiment_score": 0.37958,
"highlights": [
{
"highlight": "<em>Honeywell</em> <em>International</em[+332 characters]",
"sentiment": 0.7783,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nAccording[+319 characters]",
"sentiment": 0.0516,
"highlighted_in": "main_text"
},
{
"highlight": "Detailed estimate data is available on t[+313 characters]",
"sentiment": 0.5106,
"highlighted_in": "main_text"
},
{
"highlight": "Using the proprietary metrics from GuruF[+242 characters]",
"sentiment": 0.5574,
"highlighted_in": "main_text"
},
{
"highlight": "Further details are provided on the <em>[+70 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
}
]
}
]
}
]
}
Sentiment
Live response for past 24 hours
{
"meta": {
"returned": 1,
"limit": 10
},
"data": [
{
"key": "cl",
"total_documents": 455,
"sentiment_avg": 0.21071423111102258
}
]
}
Other details
Entity count
- 678